SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
2003
Correction on SMAD4 and Chemotherapy in Colorectal Cancer
Editorial
Author Information
Author(s): Boulay J-L, Mild G, Lowy A, Reuter J, Lagrange M, Terracciano L, Laffer U, Herrmann R, Rochlitz C
Primary Institution: Cancer Research UK
Conclusion
The erratum corrects a typesetting error in the publication regarding the disease-free survival by 5-FU treatment.
Takeaway
There was a mistake in a figure about cancer treatment, and it has been fixed.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website